Pediatrics Doctors in Royal Oak, MI Accepting Medicare

149 Pediatrics doctors found. Showing 61 - 80

Dr. Kelly Jane Daws, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-2001

Jessica Doloris Tennant, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-551-3000

Jeremy Cho, Pediatrics Medicare: Medicare Enrolled Practice Location: 3535 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-551-3000

Paul Calvin Holtrop, MD Pediatrics - Neonatal-Perinatal Medicine Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-0633    Fax: 248-898-3393

Dr. Rawad Obeid, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3555 W 13 Mile Rd Ste N300, Royal Oak, MI 48073 Phone: 248-551-7370

Dr. Kathryn Talbot, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2917 Vinsetta Blvd, Royal Oak, MI 48073 Phone: 248-589-0124    Fax: 248-589-0124

Stacey Wittenberg, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Fsc, Royal Oak, MI 48073 Phone: 248-423-2454    Fax: 248-423-2576

Dr. Akshay Vivek Nandavar, MD Pediatrics - Pediatric Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-2001    Fax: 248-898-2017

Dr. Gurpal K Jones, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd Ste Ec, Royal Oak, MI 48073 Phone: 248-898-0575

Dr. Rebecca Anne Cunningham Macfarlane, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: Beaumont Hospital- Royal Oak, 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 Phone: 248-898-5000

Michael J Maisels, MD Pediatrics - Neonatal-Perinatal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-0633    Fax: 248-898-3393

Mary Smyth, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3535 W 13 Mile Rd Ste Ll, Royal Oak, MI 48073 Phone: 248-551-3000

Christopher Bergsman, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-0377

Thomas Riggs, MD Pediatrics - Pediatric Cardiology Medicare: Not Enrolled in Medicare Practice Location: 3601 W 13 Mile Rd, Fsc, Royal Oak, MI 48073 Phone: 248-423-2454

Dr. Neal Malaykumar Trivedi, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-7999

Margaret Samberg Tabet, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3535 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-551-3000    Fax: 248-551-2032

Souheil Gebara, Pediatrics - Pediatric Gastroenterology Medicare: Medicare Enrolled Practice Location: 3535 W 13 Mile Rd, Ste. 707, Royal Oak, MI 48073 Phone: 248-551-0487

Marie Veronica Nelson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3571 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-551-0360

Dr. Riya Kaur Kalra, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3535 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-551-3000    Fax: 248-551-2032

Mr. Yong Hao Yeo, M.B.B.S. Pediatrics Medicare: Medicare Enrolled Practice Location: 3601 W Thirteen Mile Rd, Beaumont Hospital - Royal Oak, Royal Oak, MI 48073 Phone: 248-898-1493

News Archive

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.

Research findings could potentially improve early diagnosis of Alzheimer's disease

New research led by the University of Hertfordshire, may significantly change the understanding of cognitive processes that are most impaired at very early stages of Alzheimer's disease.

Peregrine Pharmaceuticals' Cotara specifically targets solid tumors and anti-tumor activity

Peregrine Pharmaceuticals, Inc. (PPHM) today reported publication of data in the online edition of the journal Current Cancer Therapy Reviews that supports the clinical potential of the company's novel brain cancer agent Cotara® for the treatment of patients with glioblastoma multiforme (GBM), the deadliest form of brain cancer. Cotara specifically targets cells at the center of brain tumors, so its radioactive payload is able to kill cancer cells while leaving healthy tissue largely unaffected. Cotara is currently being tested in a Phase II clinical trial in recurrent GBM patients.

Bathing patients in common hospital soap can reduce MRSA contamination

Holding hope for a relatively inexpensive way to improve care and prevent the spread of deadly hospital-acquired infections, a new study reports that bathing patients in a common hospital soap, called chlorhexidine, was equally effective in preventing the transmission of the methicillin-resistant Staphylococcus aureus (MRSA) as the common practice of having healthcare workers avoid physical contact with the patients.

Missouri tobacco tax proposal to appear on November ballot

The Missouri Supreme Court on Wednesday ruled unanimously that a proposed constitutional amendment to raise tobacco taxes should be placed on the Nov. 7 ballot, the St. Louis Post-Dispatch reports.

Read more Medical News

› Verified 6 days ago

• 1
• 2
• 3
• 4(current)
• 5
• 6
• 7
• 8